Hal Barron To Depart GSK To Head Up New Biotech

Tony Wood To Take Over

 
• By Andrew McConaghie

As Barron departs for new rejuvenation-focused biotech Altos Labs, GSK will be under pressure to ensure its R&D can continue to produce green shoots.

Hal Barron, Chief Scientific Officer and President R&D at GSK
Hal Barron will be CEO of the new rejuvenation-focused biotech Altos Labs • Source: GSK

More from Business

More from Scrip